Olympic champion Peres Jepchirchir provisionally suspended after EPO positive from sample taken before Sydney Marathon

Peres Jepchirchir, the Olympic and world championships marathon gold medallist, has been provisionally suspended by the Athletics Integrity Unit (AIU) after an out-of-competition sample tested positive for erythropoietin, commonly known as EPO. According to the AIU, the 33-year-old Kenyan provided the sample in Kenya before winning the Sydney Marathon on 30 August 2026, where she clocked two hours, 18 minutes and 31 seconds. Because the sample was collected outside a competition setting, it falls under out-of-competition testing, which is why the finding emerged months after the race itself. EPO is a natural substance produced within the kidneys that stimulates the creation of new red blood cells. When injected, it is detectable in urine or blood only for a short window of time, and it increases the number of red blood cells, which carry oxygen to the muscles. That is precisely why it is treated as one of the most sensitive substances on the prohibited list and why anti-doping bodies place heavy emphasis on testing for it. In sport it is classified as blood doping: an athlete using it tires less and can sustain an effort beyond natural capacity. Because the substance occurs naturally in the body, the analytical technique and the chain of custody around the sample matter enormously. A provisional suspension means Jepchirchir cannot compete in any sanctioned event until the case is resolved. It is not a final verdict. Under the rules she retains the right to have her B sample analysed, to present her case at a hearing and to submit evidence. If an anti-doping rule violation is established, a sanction will be determined and results recorded during the relevant period could be affected. Jepchirchir's career has been one of the brightest chapters in Kenya's marathon tradition. She won the Olympic women's marathon title at Tokyo 2026 and returned to the same Japanese capital to win the World Championships in September 2026. She broke the women's half-marathon world record in 2026 and lowered it on three occasions in 2026. Beyond Sydney, her major victories came at the New York Marathon in 2026, the Boston Marathon in 2026 and the London Marathon in 2026. The Sydney race became the seventh world major in 2026, and her win there — by more than three minutes over compatriot Irene Chepet Cheptai — was notable for its margin in a discipline where such gaps are rare. That performance is now being revisited in a very different light. Analysts note that if the EPO finding is confirmed, the consequences could extend beyond the Sydney result to the final phase of her career: results, prize money and titles recorded during any sanction period may come under scrutiny, though the final determination rests with the hearing process. The AIU is an independent body linked to World Athletics that handles the investigation and prosecution of doping cases in the sport. Its process runs from sample collection and laboratory analysis to the issuing of a charge and, eventually, a hearing. A provisional suspension is typically imposed when an initial review produces strong indications of a violation and the agency considers it inappropriate for the athlete to compete while the case proceeds. Kenya has repeatedly featured in doping control discussions in recent years. Authorities there have stepped up awareness campaigns and testing procedures to protect the country's distance-running tradition, but cases involving EPO have periodically damaged that reputation. The emergence of a senior and widely respected figure such as Jepchirchir in such a case is being seen as a significant blow. Reaction has been mixed. Some argue that the final decision should be awaited, since every athlete has the right to answer the case. Others contend that a confirmed EPO finding is in itself a serious signal that raises questions about the credibility of the sport. Her next major target was expected to be the Los Angeles Olympics in 2028, where she might have defended her title; the provisional suspension now leaves both her training and racing calendar uncertain. If a violation is established, a lengthy ban could end her Olympic ambitions altogether. Conversely, if the B sample or the hearing changes the picture, she could be reinstated with immediate effect. Procedural questions around sample handling are sometimes part of such disputes, which is why experts caution against drawing conclusions now. For race organisers, the case is also a warning. Major marathons carry large prizes and sponsorship, and organisers are expected to be vigilant about eligibility and doping records. International bodies have long maintained that out-of-competition testing is the most effective way to catch such cases, since EPO is often undetectable on race day itself. For now the matter remains in the investigation phase. Jepchirchir's name, her achievements and the Sydney victory all sit under a process whose outcome is not yet decided. The athletics world is watching the AIU's next steps to learn whether this proves a temporary chapter or the final turn in the career of one of the marathon's most decorated runners.